JRVMF yields 23391.81% · PFE yields 6.13%● Live data
📍 JRVMF pulled ahead of the other in Year 1
Combined, JRVMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JRVMF + PFE for your $10,000?
Jervois Global Limited explores for and evaluates mineral properties in the United States, Brazil, Finland, Australia, and internationally. The company explores for cobalt, nickel, copper, and gold deposits. It holds 100% interest in the Idaho Cobalt Operations project located in the state of Idaho; the São Miguel Paulista nickel cobalt refinery in São Paulo, Brazil; and the Nico Young nickel-cobalt deposits in New South Wales. The company is also involved in the mine construction, refinery studies, and cobalt chemical production activities. In addition, it provides a portfolio of cobalt-based products for chemical, catalyst, inorganic pigment, powder metallurgy and battery industries through its facilities in Kokkola. The company was formerly known as Jervois Mining Limited and changed its name to Jervois Global Limited in August 6, 2021. Jervois Global Limited was incorporated in 1962 and is based in Cremorne, Australia.
Full JRVMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.